ACHV Achieve Life Sciences, Inc.
$7.06▼ -3.02%
Healthcare
Other
After hours
$7.00▼ -0.85%
Sep 11, 7:58 PM ET
Volume 1.46M
Avg Volume (10D) 1.70M
Key Metrics & Fundamentals
Market Cap
$726.49M
P/E Ratio
–
Div Yield
–%
52W Range
2.62 - 8.64
% vs 50 MA
0.66%
% vs 200 MA
35.47%
RSI-14
41.7
MACD Histogram
-0.1800
Beta (1Y vs SPY)
2.05
Free Cash Flow
-$10.96M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$25.66M
COGS
–
Operating Exp
$18.39M
Operating Income
-$18.39M
EBIT
-$18.39M
Pretax Income
-$74.77M
Net Income
-$74.77M
EPS (Diluted)
-0.80
Price & Volume History
Loading chart…
Recent News
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
GlobeNewswire · Sep 3, 2026 9:15 PM
ACHV: Looking Ahead to Resubmission
Zacks Small Cap Research · Aug 18, 2026 10:21 AM
Achieve Life Sciences' Cytisinicline to Unlock $760 Million Market Opportunity in Smoking Cessation, Morgan Stanley Says
MT Newswires · Aug 13, 2026 3:46 PM
Morgan Stanley Initiates Achieve Life Sciences at Overweight, With $13 Price Target
MT Newswires · Aug 13, 2026 9:35 AM
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit.
Barchart · Aug 12, 2026 5:10 PM
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Aug 11, 2026 12:30 PM
Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality
GlobeNewswire · Aug 3, 2026 12:30 PM
Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting
MarketBeat · Jul 10, 2026 12:01 AM
Achieve Life Sciences Joins Russell 2000® Index
GlobeNewswire · Jun 29, 2026 12:30 PM
Achieve Life Sciences Receives FDA Complete Response Letter for Cytisinicline
MT Newswires · Jun 22, 2026 2:40 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ACHV's money flow as a full page
Social Sentiment
Avg +0.90 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.